18.3  -4.04 (-18.08%)		07-29 16:00
Open: 22.58 High: 23.68 Volume: 233,101		Pre. Close: 22.34 Low: 17.885 Market Cap: 412(M)

Short term
Mid term
Targets	6-month :	25.07	1-year :	27.65
Resists	First :	21.46	Second :	23.68
Pivot price	21.38
Supports	First :	17.88	Second :	14.88
MAs	MA(5) :	20.75	MA(20) :	21.63
	MA(100) :	18.73	MA(250) :	16.63
MACD	MACD :	0	Signal :	0.3
%K %D	K(14,3) :	35.8	D(3) :	33.7
RSI	RSI(14): 34.5
52-week	High :	23.68	Low :	10.73

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ NRC ] has closed below the lower bollinger band by 35.6%. Although price has broken the lower band and a downside breakout is possible; the most likely direction for [ NRC ] is to continue within current trading range. Bollinger Bands are 24.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	23.69 - 23.81	23.81 - 23.91
Low:	17.67 - 17.77	17.77 - 17.84
Close:	18.14 - 18.31	18.31 - 18.44

National Research Corporation (NRC) empowers healthcare organizations across the United States and Canada with data-driven analytics and actionable insights to enhance both patient and employee experiences. Through a comprehensive suite of subscription-based solutions, NRC supplies crucial information and analysis, addressing vital aspects such as the overall patient journey, service recovery initiatives, effective transitions of care, health risk assessments, fostering employee engagement, and enhancing reputation management and brand loyalty. Beyond these, NRC provides market intelligence to help organizations understand brand awareness, public perception, and competitive positioning. They offer advanced segmentation tools to analyze community needs, wants, and behaviors in real-time. Specialized health risk assessment tools are available to help clients pinpoint and support high-risk populations, fostering preventative care strategies and wellness initiatives. Similarly, transition management solutions assist in identifying and managing at-risk patients during care changes, aiming to reduce readmissions and ensure smooth, satisfactory transitions. NRC also offers transparency tools, empowering healthcare providers to present clear organizational information to consumers, thereby supporting informed decision-making. Furthermore, governance solutions are tailored for the leadership of non-profit hospitals and health systems, including boards of directors, executives, and physician leaders. Their clientele includes integrated health systems, post-acute care providers, and healthcare payer organizations. Established in 1981, National Research Corporation maintains its headquarters in Lincoln, Nebraska.

Wed, 29 Jul 2026
NRC Health (NRC) Stock Sinks As Margin Compression Deepens Earnings Pain - simplywall.st

Wed, 29 Jul 2026
Citizens raises NRC Health stock price target on strong results - Investing.com

Wed, 29 Jul 2026
NRC Maintained by Citizens -- Price Target Raised to $26.00 - GuruFocus

Wed, 29 Jul 2026
NRC Health (NRC) Q2 2026 Earnings Call Highlights: Strong TRCV Growth Amid Market Uncertainty - Yahoo Finance UK

Tue, 28 Jul 2026
NRC Health reports results for the quarter ended June 30 - Earnings Summary - tradingview.com

Tue, 28 Jul 2026
Earnings call transcript: NRC Health posts solid Q2 2026 growth as shares rise - Investing.com

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Healthcare Information Services
Shares Out	23 (M)
Shares Float	12 (M)
Held by Insiders	48.8 (%)
Held by Institutions	51.2 (%)
Shares Short	521 (K)
Shares Short P.Month	418 (K)

EPS	0.38
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0.6
Profit Margin	6.5 %
Operating Margin	16 %
Return on Assets (ttm)	12.2 %
Return on Equity (ttm)	41.8 %
Qtrly Rev. Growth	3.7 %
Gross Profit (p.s.)	3.8
Sales Per Share	6.15
EBITDA (p.s.)	1.53
Qtrly Earnings Growth	-44 %
Operating Cash Flow	27 (M)
Levered Free Cash Flow	20 (M)

PE Ratio	46.92
PEG Ratio	1.3
Price to Book value	30.49
Price to Sales	2.97
Price to Cash Flow	15.28

Dividend	0.15
Forward Dividend	0
Dividend Yield	0.8%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.